Related references
Note: Only part of the references are listed.Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
Pamela A. Moise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Point:: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F. Mohr et al.
CLINICAL INFECTIOUS DISEASES (2007)
Antimicrobial resistance surveillance:: VIRA STUDY 2006
Juan J. Picazo et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mortality after Staphylococcus aureus bacteraemia in two acute hospitals in Oxfordshire, 1997-2003:: cohort study
David H. Wyllie et al.
BRITISH MEDICAL JOURNAL (2006)
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia
G Sakoulas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus:: a 20 year study in a large French teaching hospital, 1983-2002
J Robert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy
G Sakoulas et al.
CLINICAL INFECTIOUS DISEASES (2006)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study
JA Cepeda et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
SH Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections
A Domenech et al.
MICROBIAL DRUG RESISTANCE (2004)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods
C Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia
TP Lodise et al.
CLINICAL INFECTIOUS DISEASES (2003)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
SK Fridkin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides
TR Walsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Spectrum and transferability of β-lactam resistance in hospital strains of Enterobacter isolated in Bratislava and Innsbruck
H Bujdáková et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
EH Ibrahim et al.
CHEST (2000)
Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia
MC Roghmann
ARCHIVES OF INTERNAL MEDICINE (2000)
Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia
A Soriano et al.
CLINICAL INFECTIOUS DISEASES (2000)
Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds
RF Pfeltz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
